Early Removal of the Urethral Catheter Following Trans-urethral Resection of Prostate

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-06-30

Study Completion Date

2021-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Transurethral resection of prostate is the gold standard operation for bladder outflow obstruction due to benign prostatic enlargement. However, catheter removal day is variable. The objective of this study is to compare early and delayed catheter removal groups in terms of, urinary retention after catheter removal, length of hospital stay, weight of resected prostate, duration of resection, peri-operative blood transfusion, and postoperative complications.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Outcomes and Efficacy of Ejaculatory Preserving Transurethral Resection of Prostate

NCT05914519

Ejaculatory Dysfunction BPH

COMPLETED NA

Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention

NCT02684344

Post-Operative Urinary Retention

TERMINATED NA

Waterjet Prostate Ablation

NCT03938194

Benign Prostatic Hyperplasia

TERMINATED NA

TURP Inpatient With Underactive Bladder With BOO

NCT06944743

TURP Syndrome Retention, Urinary Prostate Disease

RECRUITING NA

Urinary Incontinence After Radical Prostatectomy

NCT05625048

Incontinence, Urinary Radical Prostatectomy

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This randomized controlled trial will carried out in Urology clinic at Jordan university hospital. Patients with benign prostate hyperplasia will be selected by simple random sampling technique after taking informed consent and will divided into two groups: Group A- early catheter removal group( catheter removed after 24 hours) and Group B-delayed catheter removal group ( catheter removed after 48 hours). in this study we will exclude patients with large post-void urine volume, simultaneous internal urethrotomy and transurethral resection of prostate, co-morbidity( diabetes mellitus, CVA) spinal cord injury, urethral stricture, prostate cancer proved by biopsy and intra-operative complications. Patients will discharged after removal of catheter if they voided successfully.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Retention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group A- early catheter removal)

in group A, we will remove the catheter after 24 h.

removal of the urinary catheter

Intervention Type OTHER

in group A, we will remove the catheter after 24 h. In group B, we will remove the catheter after 48 h.

Group B- delayed catheter removal

In group B, we will remove the catheter after 48 h.

removal of the urinary catheter

Intervention Type OTHER

in group A, we will remove the catheter after 24 h. In group B, we will remove the catheter after 48 h.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

removal of the urinary catheter

in group A, we will remove the catheter after 24 h. In group B, we will remove the catheter after 48 h.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- All men with benign prostate hyperplasia who planned to undergo TURP will be included in this study.

Exclusion Criteria

* Large post void residual urine.
* Simultaneous internal urethrotomy and TURP.
* Uncontrolled Diabetes Mellitus (DM).
* Cerebrovascular accident accident (CVA).
* Spinal cord injury.

Minimum Eligible Age

45 Years

Maximum Eligible Age

90 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No